Cargando…
Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis
BACKGROUND: Pathogenesis of chronic pancreatitis (CP) is still not entirely understood with many patients probably having more than 1 underlying etiology. Besides toxic-metabolic factors, genetics contribute to disease development. Mutations in cystic fibrosis transmembrane conductance regulator (CF...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878632/ https://www.ncbi.nlm.nih.gov/pubmed/35212296 http://dx.doi.org/10.1097/MD.0000000000028904 |
_version_ | 1784658705499815936 |
---|---|
author | Schlosser, Tobias Fischer, Daniel Büttner, Sandra Blank, Valentin Hoffmeister, Albrecht |
author_facet | Schlosser, Tobias Fischer, Daniel Büttner, Sandra Blank, Valentin Hoffmeister, Albrecht |
author_sort | Schlosser, Tobias |
collection | PubMed |
description | BACKGROUND: Pathogenesis of chronic pancreatitis (CP) is still not entirely understood with many patients probably having more than 1 underlying etiology. Besides toxic-metabolic factors, genetics contribute to disease development. Mutations in cystic fibrosis transmembrane conductance regulator (CFTR) are shown to increase risk for CP. Activity of CFTR can easily be accessed in vivo by measurement of nasal potential difference (PD). METHODS: We compared in this monocentric study 17 CP patients from the outpatient unit of our university hospital with 30 healthy controls regarding nasal PDs by using a superfusion protocol. Additionally, demographic and lifestyle data of all persons were recorded. RESULTS: Seventeen patients (12% female, median age 48 years) with CP and 30 healthy volunteers (47% female, 25 years) were included in the study. Patients with CP had a significant higher proportion of CFTR dysfunction (P = .04). Furthermore, demographics differed between the 2 groups with CP patients being older (P < .001). There were differences in daily alcohol consumption (P = .001) and smoking habits (smokers vs nonsmokers: P = .01, pack years: P = .002). CONCLUSIONS: PD measurement is an easily accessible way to show CFTR dysfunction as an etiological factor of CP. Cigarette smoking might impair CFTR function and therefore be 1 preventable cause of CP evolution. |
format | Online Article Text |
id | pubmed-8878632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-88786322022-02-28 Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis Schlosser, Tobias Fischer, Daniel Büttner, Sandra Blank, Valentin Hoffmeister, Albrecht Medicine (Baltimore) 4500 BACKGROUND: Pathogenesis of chronic pancreatitis (CP) is still not entirely understood with many patients probably having more than 1 underlying etiology. Besides toxic-metabolic factors, genetics contribute to disease development. Mutations in cystic fibrosis transmembrane conductance regulator (CFTR) are shown to increase risk for CP. Activity of CFTR can easily be accessed in vivo by measurement of nasal potential difference (PD). METHODS: We compared in this monocentric study 17 CP patients from the outpatient unit of our university hospital with 30 healthy controls regarding nasal PDs by using a superfusion protocol. Additionally, demographic and lifestyle data of all persons were recorded. RESULTS: Seventeen patients (12% female, median age 48 years) with CP and 30 healthy volunteers (47% female, 25 years) were included in the study. Patients with CP had a significant higher proportion of CFTR dysfunction (P = .04). Furthermore, demographics differed between the 2 groups with CP patients being older (P < .001). There were differences in daily alcohol consumption (P = .001) and smoking habits (smokers vs nonsmokers: P = .01, pack years: P = .002). CONCLUSIONS: PD measurement is an easily accessible way to show CFTR dysfunction as an etiological factor of CP. Cigarette smoking might impair CFTR function and therefore be 1 preventable cause of CP evolution. Lippincott Williams & Wilkins 2022-02-25 /pmc/articles/PMC8878632/ /pubmed/35212296 http://dx.doi.org/10.1097/MD.0000000000028904 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 4500 Schlosser, Tobias Fischer, Daniel Büttner, Sandra Blank, Valentin Hoffmeister, Albrecht Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis |
title | Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis |
title_full | Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis |
title_fullStr | Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis |
title_full_unstemmed | Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis |
title_short | Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis |
title_sort | cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878632/ https://www.ncbi.nlm.nih.gov/pubmed/35212296 http://dx.doi.org/10.1097/MD.0000000000028904 |
work_keys_str_mv | AT schlossertobias cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis AT fischerdaniel cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis AT buttnersandra cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis AT blankvalentin cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis AT hoffmeisteralbrecht cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis |